ERBB2 and breast carcinoma: Estrogen receptor (ER)-positive, human epidermal growth factor-2 (HER2)-negative breast cancer represents the largest subgroup of breast cancer and associates a relatively better prognosis because of its sensitivity to targeted hormonal therapy (2).